- AU$48.16m
- AU$46.79m
- AU$0.29m
Annual balance sheet for Heramed, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.94 | 3.84 | 1.06 | 3.17 | 1.37 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.137 | 0.681 | 0.504 | 0.125 | 0.041 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 5.36 | 4.77 | 1.93 | 3.71 | 1.45 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.04 | 0.111 | 0.076 | 0.038 | 0.003 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 6.32 | 6.41 | 2.95 | 4.48 | 1.49 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.71 | 1.47 | 1.51 | 1.05 | 0.323 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.47 | 2.21 | 2.27 | 1.71 | 0.56 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.146 | 4.2 | 0.686 | 2.77 | 0.931 |
| Total Liabilities & Shareholders' Equity | 6.32 | 6.41 | 2.95 | 4.48 | 1.49 |
| Total Common Shares Outstanding |